NYSE · Medical - Equipment & Services

Envista Holdings Corporation (NVST) Stock

$22.82 +0.44% NYSE: NVST Healthcare

Valuation

MetricValue
Price$22.82
Market Cap$3.71B
P/E Ratio39.76
P/B Ratio1.23
P/S Ratio1.34
EPS (TTM)$0.28
52-Week High$30.42
52-Week Low$18.77
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE3.08%
ROA1.70%
ROCE5.92%
Gross Margin8.31%
Operating Margin8.31%
Net Margin3.33%
Debt/Equity0.52
Current Ratio2.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.5B$2.6B$2.6B$2.5B$2.7B
Operating Profit$306.0M$319.0M$32.0M$-1.0B$226.0M
Net Profit$341.0M$243.0M$-100.0M$-1.1B$47.0M
EPS$1.48$1.34$-0.60$-6.50$0.28
Op Margin12.2%12.4%1.2%-41.4%8.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.6B$6.6B$6.6B$5.4B$5.7B
Total Liabilities$2.5B$2.4B$2.4B$2.4B$2.6B
Cash$1.1B$607.0M$940.0M$1.1B$1.2B
Borrowings$1.5B$1.5B$1.7B$1.5B$1.6B

Latest News

1 Profitable Stock with Impressive Fundamentals and 2 We Question StockStory · Jul 14, 2026 Q1 Dental Equipment & Technology Earnings Review: First Prize Goes to Envista (NYSE:NVST) StockStory · Jul 13, 2026 Envista (NVST) Stock Looks Cheap On Cash Flow But Pricey On Earnings Simply Wall St. · Jul 10, 2026 Does NVST Stock Still Deserve a Place in Your Portfolio? Zacks · Jul 9, 2026 BMO Capital Initiates Envista Holdings at Market Perform With $27 Price Target MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$362.0M$183.0M$276.0M$337.0M$276.0M
Investing Cash Flow$208.0M$-733.0M$-121.0M$-88.0M$-96.0M
Financing Cash Flow$-9.0M$-9.0M$-8.0M$-6.0M$-173.0M
Net Cash Flow$185.0M$-467.0M$333.0M$129.0M$143.0M
Free Cash Flow$307.0M$107.0M$218.0M$303.0M$230.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.44
EV / EBITDA12.18
FCF Yield6.08%
Quick Ratio2.07
Interest Coverage13.76
Return 1Y27.67%
Return 3Y-18.04%
Return 5Y-35.65%

Ownership

Insiders Held0.48%
Institutions Held113.61%
Institutions Float Held114.16%
Institutional HolderSharesReport Date
Blackrock Inc.17,852,8272026-03-31
Ariel Investments, LLC10,863,5922026-03-31
Dimensional Fund Advisors LP9,780,9482026-03-31
Morgan Stanley8,793,1372026-03-31
Vanguard Portfolio Management LLC7,566,7212026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALHCAlignment Healthcare, Inc. $7.63 -12.45% 41.70 $1.58B 0.00%
APGE $135.07 +0.00% -16.89 $8.36B 0.00%
CONConcentra Group Holdings Parent, Inc. $36.91 +0.81% 23.00 $4.72B 0.70%
DYNDyne Therapeutics, Inc. $16.65 +1.71% -4.84 $3.11B 0.00%
GRALGRAIL, Inc. $141.98 +7.07% -14.69 $6.09B 0.00%

About Envista Holdings Corporation

Envista Holdings Corporation (NVST) stock trades at $22.82 with a market capitalization of $3.71B. The stock is valued at a price-to-earnings (P/E) ratio of 39.76, price-to-book of 1.23, price-to-sales of 1.34. Over the past 52 weeks the stock has ranged between $18.77 and $30.42, and currently trades 25.0% below its 52-week high.

On profitability, Envista Holdings Corporation generates a return on equity (ROE) of 3.08%, return on capital employed of 5.92%, an operating margin of 8.31%, a net profit margin of 3.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides